The global bone growth stimulators market is set to hit $1.41 billion by 2022, according to a Research and Markets report.
Here are five points:
1. The global market is anticipated to grow at a compound annual growth rate of 5.4 percent through 2022.
2. An increasing demand for minimally invasive surgery as well as a growing aging population will drive the market.
3. The cost-effectiveness of bone stimulation devices as opposed to alternative options for bone fracture treatments will also spur market growth.
4. The spinal fusion market segment captured the largest market share in 2016, due to the proven safety and efficacy of spinal stimulators and high volume of spine cases.
5. Key market companies include Altis Biologics, Arthrex, Bioventus, DJO Finance, DePuy Synthes, Ember Therapeutics, Harvest Technologies, ITO Co., Isto Biologics, Medtronic, Orthofix International, Regen Lab, Stryker and Zimmer Biomet.